APA (7th ed.) Citation

S, R., L, B., A, D., LM, D., G, E., F, E., . . . K, B. (2026). Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: A German expert consensus report. Frontiers in immunology, 17, 1846251. https://doi.org/10.3389/fimmu.2026.1846251

Chicago Style (17th ed.) Citation

S, Reuter, et al. "Risk-adapted HLA Delisting and Imlifidase-enabled Deceased-donor Kidney Transplantation in Highly Sensitized Kidney Transplant Candidates: A German Expert Consensus Report." Frontiers in Immunology 17 (2026): 1846251. https://doi.org/10.3389/fimmu.2026.1846251.

MLA (9th ed.) Citation

S, Reuter, et al. "Risk-adapted HLA Delisting and Imlifidase-enabled Deceased-donor Kidney Transplantation in Highly Sensitized Kidney Transplant Candidates: A German Expert Consensus Report." Frontiers in Immunology, vol. 17, 2026, p. 1846251, https://doi.org/10.3389/fimmu.2026.1846251.